Live feed
·
INSIDERFiling
Neurocrine Biosciences Inc. logo

Chief Executive Officer Gano Kyle converted options into 9,714 shares, covered exercise/tax liability with 10,621 shares and was granted 9,968 shares, increasing direct ownership by 6% to 150,815 units (SEC Form 4)